IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026Newsfile Corp • 04/28/26
IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law FirmPRNewsWire • 04/28/26
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Chairman Allegedly Made False Drug Claims: Levi & KorsinskyGlobeNewsWire • 04/27/26
ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLPPRNewsWire • 04/27/26
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRXNewsfile Corp • 04/26/26
IBRX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026Newsfile Corp • 04/26/26
ImmunityBio, Inc. (IBRX) Securities Fraud Class Action Lawsuit Filed; May 26, 2026, Lead Plaintiff DeadlineGlobeNewsWire • 04/25/26
ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRXGlobeNewsWire • 04/25/26
IBRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ImmunityBio, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action LawsuitGlobeNewsWire • 04/25/26
IBRX Lawsuit Alleges Misleading Cancer Claims - ImmunityBio Investors Face Losses Following $2B Market Cap Loss – Hagens BermanGlobeNewsWire • 04/24/26
IBRX EQUITY ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026Newsfile Corp • 04/24/26
INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit- Hagens BermanPRNewsWire • 04/23/26
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRXNewsfile Corp • 04/23/26
IBRX Lawsuit Alleges Company Allegedly Violated Drug Promotion Laws - ImmunityBio Investors Face Losses Following Company Allegedly Violated Drug Promotion Laws: SueWallStPRNewsWire • 04/23/26
ROSEN, A LONGSTANDING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRXGlobeNewsWire • 04/22/26
IBRX INVESTOR ALERT: Berger Montague Advises ImmunityBio, Inc. (IBRX) Investors of a May 26, 2026 DeadlineNewsfile Corp • 04/22/26
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After FDA Allegedly Exposed Misleading Claims: Levi & KorsinskyPRNewsWire • 04/22/26
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRXNewsfile Corp • 04/21/26
IMMUNITYBIO, INC. (IBRX) DEADLINE ALERT Bernstein Liebhard LLP Reminds ImmunityBio, Inc. Investors of Upcoming DeadlineNewsfile Corp • 04/21/26
IBRX Shareholder Alert: May 26, 2026 Lead Plaintiff Deadline in ImmunityBio, Inc. Securities Class Action Lawsuit -- The Gross Law FirmPRNewsWire • 04/21/26